- Research works
- 87 ▼ 23% vs 2013–17
- Citations
- 2.7k 30.5 per fractional work
- Top-10% rate
- 15.2% record average 16.5%
- Open access
- 31% world 28%
Not ranked overall: Biopredic (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 20.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 20.7×
- Veterinary 10.4×
- Biochemistry, Genetics and Molecular Biology 8.3×
- Immunology and Microbiology 2.7×
- Medicine 1.7×
- Chemistry 0.8×
- Mathematics 0.7×
- Environmental Science 0.4×
- Arts and Humanities 0.4×
- Computer Science 0.3×
- Engineering 0.2×
- Social Sciences 0.0×
- Decision Sciences 0.0×
- Health Professions 0.0×
Which keywords describe research at Biopredic (France)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Genomics, Mutational Signatures, Immunotherapy, Gene Expression, Biomarkers, Genetic Mutations, Quantitative and Pharmacokinetics.
- Real-Time PCR
- Normalization
- Clinical Trials
- Pharmacokinetics
- Genetic Mutations
- Gene Expression
- Mutational Signatures
- Cancer Genomics
- Immunotherapy
- Biomarkers
- Quantitative
- Cancer
- Androgen Receptor
- Prostate Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Cancer Genomics4▲ 233×1 topic
- Mutational Signatures4▲ 233×1 topic
- Immunotherapy3▲ 19×8 topics
- Gene Expression2▲ 15×3 topics
- Biomarkers2▲ 12×4 topics
- Genetic Mutations2▲ 19×2 topics
- Quantitative2▲ 80×2 topics
- Pharmacokinetics1▲ 24×2 topics
- Cancer1▲ 4.3×3 topics
- Clinical Trials1▲ 7.7×3 topics
- Androgen Receptor1▲ 67×1 topic
- Normalization1▲ 96×1 topic
- Prostate Cancer1▲ 37×1 topic
- Real-Time PCR1▲ 180×1 topic
Which research topics does Biopredic (France) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research, Molecular Biology Techniques and Applications and Pharmacogenetics and Drug Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 4 works
- 2 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 3 Molecular Biology Techniques and Applications Molecular Biology 1 works
- 4 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
- 5 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 1 works
- 6 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 7 Liver Disease Diagnosis and Treatment Epidemiology 1 works
- 8 Cancer-related molecular mechanisms research Cancer Research 1 works
- 9 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 10 Biosimilars and Bioanalytical Methods Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biopredic (France)'s research output changed?
Output in 2018–2022 was 23% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Saint-Grégoire
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.